oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Middle Ear Application of Hyaluronic Acid Gel Loaded with Neomycin in a Guinea Pig Model
Department of Clinical Neuroscience, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Sciences, Umeå University, Umeå, Sweden.
Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Show others and affiliations
2008 (English)Conference paper, Poster (with or without abstract) (Refereed)
Abstract [en]

Background: One alternative for controlled drug delivery to the inner ear is application of medication to the middle ear cavity on the promise that it will diffuse through the round window membrane (RWM) into the inner ear.

Objective: to evaluate the efficacy of hyaluronic acid gel (HYA) as a vehicle for drugs that are aimed to treat inner ear disorders.

Methods: in this study the cochlear hair cell loss and RWM morphology were investigated after topical application. Neomycin was chosen as tracer for drug release and the ototoxic effect was evaluated. HYA, (0.5%) loaded with 3 different concentrations of neomycin, was injected to the middle ear cavity of guinea pigs. the ototoxic effect of neomycin in HYA gel was compared to that of neomycin solution applied to the middle ear cavity. Phalloidin stained surface preparation of the organ of Corti was used to estimate hair cell loss induced by neomycin. the thickness of the midportion of the RWM was measured and compared with that of controls using light and electrom microscope.

Result: Neomycin induced a considerable hair cell loss in guinea pigs receiving middle ear injection of HYA loaded with the drug. One week after topical application the thickness of the RWM was dependent upon the concentration of neomycin administered to the middle ear. At 4 weeks the thickness of the RWM had returned to normal.

Conclusion: HYA is a safe vehicle for drugs aimed to pass into the inner ear through the RWM. Neomycin was released from HYA and transported into the inner ear as evidenced by hair cell loss. Key words: Round window membrane (RWM), hyaluronic acid gel, HYA, hair cell loss, thickness.

Place, publisher, year, edition, pages
2008.
National Category
Otorhinolaryngology Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:oru:diva-69319OAI: oai:DiVA.org:oru-69319DiVA, id: diva2:1253739
Conference
31st Annual MidWinter Meeting of the Association for Research in Otolaryngology, Phoenix, AZ, USA, February 16-21, 2008
Available from: 2018-10-05 Created: 2018-10-05 Last updated: 2019-07-10Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Saber, Amanj

Search in DiVA

By author/editor
Saber, Amanj
OtorhinolaryngologyPharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 79 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf